XML 135 R117.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Contingencies and commitments (EPOGEN Patent Litigation) (Details) $ in Millions | Sep. 22, 2017 USD ($) | Jan. 23, 2017 claim
--- | --- | ---
Hospira EPOGEN Patent Litigation |  |
Gain Contingencies [Line Items] |  |
Aount awarded from other party | $ | $ 70 |
Epoetin Alfa Litigation |  |
Gain Contingencies [Line Items] |  |
Number of patents allegedly infringed | claim |  | 2
Length of trial | 5 days |

X
- Definition Litigation Settlement, Length of Trial + References No definition available. + Details
Name: | amgn_LitigationSettlementLengthofTrial
Namespace Prefix: | amgn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_GainContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of entity's patents that another entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount awarded from other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_GainContingenciesByNatureAxis=amgn_HospiraEPOGENPatentLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=amgn_EpoetinAlfaLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |